Plasmodium vivax: Clinical Spectrum, Risk Factors and Pathogenesis

Advances in Parasitology

Volumn 80, Issue , 2012, Pages 151-201

  Anstey, Nicholas M ^a,b   Douglas, Nicholas M ^a,b   Poespoprodjo, Jeanne R ^c,d   Price, Ric N ^a,b,e  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b ROYAL DARWIN HOSPITAL   (Australia)

^c Central Papua   (Indonesia)

^d Department of Pediatrics   (Indonesia)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Malaria; Pathogenesis; Plasmodium vivax; Severe malaria

Indexed keywords

ANTIANEMIC AGENT; ANTIMALARIAL AGENT; CHLOROQUINE; IRON; PRIMAQUINE; ZINC;

ACADEMIC ACHIEVEMENT; ACUTE KIDNEY FAILURE; ACUTE LUNG INJURY; ANEMIA; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BIOMASS; CELL ADHESION; COMA; COMORBIDITY; CONGENITAL INFECTION; DISEASE SEVERITY; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE FRAGILITY; FEVER; GENETIC POLYMORPHISM; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; GROUPS BY AGE; GROWTH DISORDER; HEMOLYSIS; HEMOSTASIS; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCUBATION TIME; INFECTION RISK; INFECTION SENSITIVITY; KIDNEY DYSFUNCTION; LOW BIRTH WEIGHT; MALNUTRITION; MIXED INFECTION; MULTIPLE ORGAN FAILURE; NEUROLOGICAL COMPLICATION; NONHUMAN; PARASITE VIRULENCE; PATHOGENESIS; PATHOPHYSIOLOGY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PREGNANCY; PRIORITY JOURNAL; RECURRENT INFECTION; RESPIRATORY DISTRESS; ROSETTE FORMATION; SHOCK; SPLEEN INFARCTION; SPLEEN RUPTURE; THROMBOCYTOPENIA;

EID: 84870344853     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-397900-1.00003-7     Document Type: Chapter

References (294)

1. Abu Sayeed A., et al. Malarial retinopathy in Bangladeshi adults. Am. J. Trop. Med. Hyg. 2011, 84(1):141-147.
2. Adams F. The Genuine Works of Hippocrates 1849, Sydenham Society, London.
3. Agarwal R., Nath A., Gupta D. Noninvasive ventilation in Plasmodium vivax related ALI/ARDS. Intern. Med. 2007, 46(24):2007-2011.
4. Alexandre M.A., et al. Severe Plasmodium vivax malaria, Brazilian Amazon. Emerg. Infect. Dis. 2010, 16(10):1611-1614.
5. Andrade B.B., et al. Plasma superoxide dismutase-1 as a surrogate marker of vivax malaria severity. PloS Negl. Trop. Dis. 2010, 4(4):e650.
6. Andrade B.B., et al. Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. Malar. J. 2010, 9:13.
7. Anstey N.M., et al. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J. Exp. Med. 1996, 184(2):557-567.
8. Anstey N.M., et al. Pulmonary manifestations of uncomplicated falciparum and vivax malaria: cough, small airways obstruction, impaired gas transfer, and increased pulmonary phagocytic activity. J. Infect. Dis. 2002, 185(9):1326-1334.
9. Anstey N.M., et al. Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. J. Infect. Dis. 2007, 195(4):589-596.
10. Anstey N.M., et al. The pathophysiology of vivax malaria. Trends Parasitol. 2009, 25:220-227.
11. Anstey N.M., Price R.N. Improving case definitions for severe malaria. PLoS Med. 2007, 4(8):e267.
12. Antia R., Yates A., de Roode J.C. The dynamics of acute malaria infections. I. Effect of the parasite's red blood cell preference. Proc. Biol. Sci. 2008, 275(1641):1449-1458.
13. Arora R.C., et al. Cerebral malaria caused by Plasmodium vivax. J. Assoc. Physicians India 1988, 36:564.
14. Baird J.K., Surjadjaja C. Consideration of ethics in primaquine therapy against malaria transmission. Trends Parasitol. 2010.
15. Baird J.K. Neglect of Plasmodium vivax malaria. Trends Parasitol. 2007, 23(11):533-539.
16. Baird J.K. Severe and fatal vivax malaria challenges 'benign tertian malaria' dogma. Ann. Trop. Paediatr. 2009, 29:251-252.
17. Barber B.E., William T., Grigg M.J., Menon J., Auburn S., Marfurt J., Anstey N.M., Yeo T.W. A prospective comparative study of knowlesi, falciparum and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and P. vivax but no mortality with early referral and artesunate therapy. Clin. Infect. Dis. 2012, 10.1093/cid/cis902.
18. Barcus M.J., et al. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am. J. Trop. Med. Hyg. 2007, 77(5):984-991.
19. Bassat Q., Alonso P.L. Defying malaria: fathoming severe Plasmodium vivax disease. Nat. Med. 2011, 17(1):48-49.
20. Beare N.A., et al. Malarial retinopathy: a newly established diagnostic sign in severe malaria. Am. J. Trop. Med. Hyg. 2006, 75(5):790-797.
21. Beg M., et al. Cerebral involvement in benign tertian malaria. Am. J. Trop. Med. Hyg. 2002, 67:230-232.
22. Bejon P., et al. Defining childhood severe falciparum malaria for intervention studies. PLoS Med. 2007, 4(8):e251.
23. Berkley J., et al. Bacteraemia complicating severe malaria in children. Trans. R Soc. Trop. Med. Hyg. 1999, 93:283-286.
24. Berkley J.A., et al. HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria. Clin. Infect. Dis. 2009, 49(3):336-343.
25. Bhattacharya J., Swarup-Mitra S. Reduction in erythrocytic GSH level and stability in Plasmodium vivax malaria. Trans. R Soc. Trop. Med. Hyg. 1987, 81(1):64-66.
26. Billings F., Post W. Fatal malaria due to the tertian parasite. Trans. Chicago Path Soc. 1915, 9:209-215.
27. Bircan Z., et al. Two cases of nephrotic syndrome and tertian malaria in south-eastern Anatolia. Pediatr. Nephrol. 1997, 11(1):78-79.
28. Biswas J., et al. Ocular malaria. A clinical and histopathologic study. Ophthalmology 1996, 103(9):1471-1475.
29. Bloland P.B., et al. Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children. Am. J. Trop. Med. Hyg. 1999, 60(4):641-648.
30. Boshes B. Neuropyschiatric manifestations during the course of malaria. Arch. Neurol. Pyschiatr. 1947, 58:14-27.
31. Boutlis C.S., et al. Glycosylphosphatidylinositols in malaria pathogenesis and immunity: potential for therapeutic inhibition and vaccination. Curr. Top. Microbiol. Immunol. 2005, 297:145-185.
32. Boyd M.F. The threshold of parasite density in relation to clinical activity in primary infections with Plasmodium vivax. Am. J. Trop. Med. 1938, s1-18(5):497-503.
33. Boyd M.F. Historical Introduction. A Symposium on Human Malaria 1941, 163. Am Assoc Advancement Sci, Washington DC.
34. Brooker S., et al. Epidemiology of Plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control. Am. J. Trop. Med. Hyg. 2007, 77(Suppl. 6):88-98.
35. Bruetsch W. The histopathology of therapeutic (tertian) malaria. Am. J. Psychiatry 1932, 12:19-65.
36. Bruetsch W.L. The histopathology of therapeutic (tertian) malaria. Am. J. Psychiatry 1932, 89(1):19-65.
37. Buck R.L., et al. Malaria at San Lazaro hospital, Manila, Philippines, 1979-1981. Am. J. Trop. Med. Hyg. 1983, 32(2):212-216.
38. Burgmann H., et al. Serum levels of erythropoietin in acute Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 1996, 54(3):280-283.
39. Carlini M.E., White A.C., Atmar R.L. Vivax malaria complicated by adult respiratory distress syndrome. Clin. Infect. Dis. 1999, 28(5):1182-1183.
40. Carlson J., et al. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 1990, 336(8729):1457-1460.
41. Carlton J.M., et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 2008, 455(7214):757-763.
42. Carrara V.I., et al. Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative. PLoS Med. 2006, 3(6):e183.
43. Carvalho B.O., et al. On the Cytoadhesion of Plasmodium vivax-infected erythrocytes. J. Infect. Dis 2010.
44. Chakravarty A., et al. Acute inflammatory demyelinating polyneuropathy following plasmodium vivax malaria. Neurol. India 2004, 52(1):130-131.
45. Chang K.-H., Stevenson M.M. Malarial anaemia: mechanisms and implications of insufficient erythropoiesis during blood-stage malaria. Int. J. Parasitol. 2004, 34(13-14):1501-1516.
46. Chen N., et al. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J. Infect. Dis. 2007, 195:934-941.
47. Choi H.J., et al. Retinal haemorrhage in vivax malaria. Trans. R Soc. Trop. Med. Hyg. 2004, 98(6):387-389.
48. Chotivanich K., et al. Plasmodium vivax adherence to placental glycosaminoglycans. PLoS ONE 2012, 7(4):e34509.
49. Chung B.H., et al. Predictors of Plasmodium vivax malaria-induced nephropathy in young Korean men. Nephron Clin. Pract. 2008, 110(3):c172-c177.
50. Clark H., Tomlinson W. The pathologic anatomy of malaria. Malariology 1949, 874-903. WB Saunders, Philadelphia. M. Boyd (Ed.).
51. Coatney G.R., et al. The Primate Malarias 1971, National Institutes of Health, Bethesda, Md, p. 1-366.
52. Collins W.E., Jeffery G.M., Roberts J.M. A retrospective examination of anemia during infection of humans with Plasmodium vivax. Am. J. Trop. Med. Hyg. 2003, 68(4):410-412.
53. Cunnington A.J., et al. Malaria impairs resistance to Salmonella through heme- and heme oxygenase-dependent dysfunctional granulocyte mobilization. Nat. Med. 2012, 18(1):120-127.
54. Curley J.M., Mody R.M., Gasser R.A. Malaria caused by Plasmodium vivax complicated by acalculous cholecystitis. Am. J. Trop. Med. Hyg. 2011, 85(1):42-49.
55. Curlin M.E., et al. Noncardiogenic pulmonary edema during vivax malaria. Clin. Infect. Dis. 1999, 28(5):1166-1167.
56. Daneshvar C., et al. Clinical and laboratory features of human Plasmodium knowlesi infection. Clin. Infect. Dis. 2009, 49(6):852-860.
57. David J., Shanbag P., More V. Plasmodium vivax malaria presenting as the nephrotic syndrome in an infant. Trop. Doct 2009, 39(2):127-128.
58. Davis J.S., et al. Sepsis in the tropical Top end of Australia's northern Territory: disease burden and impact on indigenous Australians. Med. J. Aust. 2011, 194(10):519-524.
59. Day N.P., et al. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J. Infect. Dis. 1999, 180(4):1288-1297.
60. de Mast Q., et al. ADAMTS13 deficiency with elevated levels of ultra-large and active von Willebrand factor in malaria (abstract). Am. J. Trop. Med. Hyg. 2008, 79:s348.
61. de Mast Q., et al. ADAMTS13 deficiency with elevated levels of ultra-large and active von Willebrand factor in P. falciparum and P. vivax malaria. Am. J. Trop. Med. Hyg. 2009, 80(3):492-498.
62. Del Punta V., et al. Congenital Plasmodium vivax malaria mimicking neonatal sepsis: a case report. Malar. J. 2010, 9:63.
63. Deplaine G., et al. The sensing of poorly deformable red blood cells by the human spleen can be mimicked in vitro. Blood 2011, 117(8):e88-95.
64. Dhayagude R.G., Purandare N.M. Autopsy study of cerebral malaria with reference to malarial granulomas. Arch. Pathol. 1943, 36:550-558.
65. Dobson M. Contours of Death and Disease in Early Modern England 1997, Cambridge University Press, Cambridge.
66. Dondorp A.M., et al. Red blood cell deformability as a predictor of anemia in severe falciparum malaria. Am. J. Trop. Med. Hyg. 1999, 60(5):733-737.
67. Dondorp A.M., et al. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med. 2005, 2:e204.
68. Dondorp A.M., et al. The relationship between age and the manifestations of and mortality associated with severe malaria. Clin. Infect. Dis. 2008, 47(2):151-157.
69. Douglas N.M., et al. Artemisinin combination therapy for vivax malaria. Lancet Infect. Dis. 2010, 10:405-416.
70. Douglas N.M., et al. The anaemia of Plasmodium vivax malaria. Malar. J. 2012, 11(1):135.
71. el Hassan A.M., et al. Decreased erythropoietin response in Plasmodium falciparum malaria-associated anaemia. Eur. J. Haematol. 1997, 59(5):299-304.
72. Eldridge W., et al. Treatment of paresis: results of inoculation with the organism of benign tertian malaria. J. Am. Med. Assoc. 1925, 84:1097-1101.
73. Erel O., et al. Oxidative stress and antioxidative status of plasma and erythrocytes in patients with vivax malaria. Clin. Biochem. 1997, 30(8):631-639.
74. Ewing J. Malarial parasitology. J. Exp. Med. 1901, 5:429-491.
75. Falconer A. The pulmonary manifestations in malaria. QJM 1919, 13:25-34.
76. Fernando S.D., et al. The impact of repeated malaria attacks on the school performance of children. Am. J. Trop. Med. Hyg. 2003, 69(6):582-588.
77. Fernando D., de Silva D., Wickremasinghe R. Short-term impact of an acute attack of malaria on the cognitive performance of schoolchildren living in a malaria-endemic area of Sri Lanka. Trans. R Soc. Trop. Med. Hyg. 2003, 97(6):633-639.
78. Field J., Shute P. Plasmodium vivax. The Microscopic Diagnosis of Human Malaria. A Morphological Study of the Erythrocytic Parasites 1956, vol. 2. Institute for Medical Research, Kuala Lumpur.
79. Flower B., et al. Blind, breathless, and paralysed from benign malaria. Lancet 2011, 377(9763):438.
80. Fong T. A study of the mortality rate and complications following therapeutic malaria. South. Med. J. 1937, 30:1084-1088.
81. Fowkes F.J., et al. Increased microerythrocyte count in homozygous alpha(+)-thalassaemia contributes to protection against severe malarial anaemia. PLoS Med. 2008, 5(3):e56.
82. Franklin B.S., et al. Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function. Proc. Natl. Acad. Sci. U S A 2009, 106(14):5789-5794.
83. Freeman W., Eldridge W., Hall R. Malaria treatment of dementia paralytica: results in 205 cases after five to eleven years. South. Med. J. 1934, 27:122-126.
84. Gamage-Mendis A.C., et al. Clustering of malaria infections within an endemic population: risk of malaria associated with the type of housing construction. Am. J. Trop. Med. Hyg. 1991, 45(1):77-85.
85. Gandapur A.S., Malik S.A., Raziq F. Bone marrow changes in human malaria: a retrospective study. J. Pak. Med. Assoc. 1997, 47(5):137-139.
86. Genton B., et al. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med. 2008, 5(6):e127.
87. Gilles H.M., Hendrickse R.G. Possible aetiological role of Plasmodium malariae in "nephrotic syndrome" in Nigerian children. Lancet 1960, 1(7128):806-807.
88. Gilles H.M., Hendrickse R.G. Nephrosis in Nigerian children. Role of Plasmodium malariae, and effect of antimalarial treatment. Br. Med. J. 1963, 2(5348):27-31.
89. Golgi C. Sull" infezione malarica. Archivo Per Le Scienze Mediche 1886, 10:109-135.
90. Golgi C. On the cycle of development of malarial parasites in tertian fever: differential diagnosis between the intracellular malarial parasites of tertian and quartan fever. Archivo Per Le Scienza Mediche 1889, 13:173-196.
91. Goller J.L., et al. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy. Am. J. Trop. Med. Hyg. 2007, 76(2):203-207.
92. Gopinathan V.P., Subramaniam A.R. Pernicious syndromes in Plasmodium infections. Med. J. Aust. 1982, 2:568-572.
93. Gopinathan V.P., Subramanian A.R. Vivax and falciparum malaria seen at an Indian service hospital. J. Trop. Med. Hyg. 1986, 89(2):51-55.
94. Grau G.E., et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N. Engl. J. Med. 1989, 320(24):1586-1591.
95. Gupta B.K., et al. A case series of splenic infarction during acute malaria in northwest Rajasthan, India. Trans. R Soc. Trop. Med. Hyg. 2010, 104(1):81-83.
96. Gwamaka M., et al. Iron deficiency protects against severe Plasmodium falciparum malaria and death in young children. Clin. Infect. Dis. 2012, 54(8):1137-1144.
97. Habib A.G., Singh K.S. Respiratory distress in nonimmune adults with imported malaria. Infection 2004, 32(6):356-359.
98. Handayani S., et al. High deformability of Plasmodium vivax-infected red blood cells under microfluidic conditions. J. Infect. Dis. 2009, 199(3):445-450.
99. Hankey D.D., et al. Korean vivax malaria. I. Natural history and response to chloroquine. Am. J. Trop. Med. Hyg. 1953, 2(6):958-969.
100. Harish R., Gupta S. Plasmodium vivax malaria presenting with severe thrombocytopenia, cerebral complications and hydrocephalus. Indian J. Pediatr. 2009, 76(5):551-552.
101. Harris I., et al. A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting. Malar. J. 2010, 9:254.
102. Harvey P.W., et al. The effect of iron therapy on malarial infection in Papua New Guinean schoolchildren. Am. J. Trop. Med. Hyg. 1989, 40(1):12-18.
103. Hemmer C.J., et al. Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria. Trop. Med. Int. Health 2006, 11(6):817-823.
104. Hill G.J., et al. Vivax malaria complicated by aphasia and hemiparesis. Arch. Intern. Med. 1963, 12:863-868.
105. Hutchinson R.A., Lindsay S.W. Malaria and deaths in the English marshes. Lancet 2006, 367(9526):1947-1951.
106. Hyman A. Clinical masquerades of malaria. Nav. Med. Bull. 1945, 45:287-303.
107. Imbert P., et al. Left upper quadrant abdominal pain in malaria: suspect pathological splenic rupture first. Trans. R Soc. Trop. Med. Hyg. 2010, 104(9):628.
108. Imbert P., Rapp C., Buffet P.A. Pathological rupture of the spleen in malaria: analysis of 55 cases (1958-2008). Travel Med. Infect. Dis. 2009, 7(3):147-159.
109. Imwong M., et al. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J. Infect. Dis. 2007, 195(7):927-933.
110. Jakeman G.N., et al. Anaemia of acute malaria infections in non-immune patients primarily results from destruction of uninfected erythrocytes. Parasitology 1999, 119(Pt 2):127-133.
111. Jakobsen P.H., et al. Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or Plasmodium vivax malaria and association with disease severity. Immunology 1994, 83:665-669.
112. James S., Nicol W., Shute P. Clinical and parasitological observations on induced malaria. Proc. R Soc. Med. 1936, 29:879-894.
113. James S.P. The disappearance of malaria from England. Proc. R Soc. Med. 1925, 23:71-85.
114. James S.P. Report on the First Laboratory Work in Malaria in England 1926, League of Nations Health Organisation, Geneva.
115. James S.P. Some general results of a study of induced malaria in England. Trans. R Soc. Trop. Med. Hyg. 1931, 24:477.
116. James S. Third general report of the malaria Commission of the health Organization of the League of Nations. Quart Bull. Health Org. League Nation. 1933, 2:217.
117. Jat K.R., Guglani V., Khairwa A. Severe and complicated Plasmodium vivax malaria in children. Trop. Doct 2012.
118. Kanodia K.V., et al. Malaria induced acute renal failure: a single center experience. Saudi J. Kidney Dis. Transpl. 2010, 21(6):1088-1091.
119. Kapland L.I., Read H.S., Mullins D.F. Spontaneous rupture of the spleen during malaria therapy; report of a case. Ann. Intern. Med. 1946, 24:707-714.
120. Kapoor K., Gupta S. Malarial acute kidney injury in a paediatric intensive care unit. Trop. Doct. 2012, (p. epub ahead of print).
121. Karunaweera N.D., et al. Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients. Clin. Exp. Immunol. 1992, 88(3):499-505.
122. Karunaweera N.D., et al. The paroxysm of Plasmodium vivax malaria. Trends Parasitol. 2003, 19(4):188-193.
123. Karunaweera N., et al. Plasmodium vivax: paroxysm-associated lipids mediate leukocyte aggregation. Malar. J. 2007, 6:62.
124. Karyana M., et al. Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum. Malar. J. 2008, 7(1):148.
125. Kasliwal P., Rao M.S., Kujur R. Plasmodium vivax malaria: an unusual presentation. Indian J. Crit. Care Med. 2009, 13(2):103-105.
126. Kaushik J.S., Gomber S., Dewan P. Clinical and epidemiological profiles of severe malaria in children from Delhi, India. J. Health Popul. Nutr. 2012, 30(1):113-116.
127. Kern P., et al. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am. J. Med. 1989, 87(2):139-143.
128. Kim E.M., et al. Abdominal computed tomography findings of malaria infection with Plasmodium vivax. Am. J. Trop. Med. Hyg. 2010, 83(6):1202-1205.
129. Kitchen S.F. The infection of reticulocytes by Plasmodium vivax. Am. J. Trop. Med. Hyg. 1938, s1-18(4):347-359.
130. Kitchen S. Symptomatology: general Considerations. Malariology 1949, 966-994. W.B. Saunders, Philadelphia. M.F. Boyd (Ed.).
131. Kitchen S.F. Vivax Malaria. Malariology 1949, 1027-1045. W.B. Saunders, Philadelphia. M.F. Boyd (Ed.).
132. Kochar D.K., et al. Plasmodium vivax malaria. Emerg. Infect. Dis. 2005, 11:132-134.
133. Kochar D.K., et al. Post-malaria neurological syndrome-a case of bilateral facial palsy after Plasmodium vivax malaria. J. Vector Borne Dis. 2007, 44(3):227-229.
134. Kochar D.K., et al. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am. J. Trop. Med. Hyg. 2009, 80(2):194-198.
135. Kochar D.K., et al. Clinical features of children hospitalized with malaria-a study from Bikaner, northwest India. Am. J. Trop. Med. Hyg. 2010, 83(5):981-989.
136. Koibuchi T., et al. Acute disseminated encephalomyelitis following Plasmodium vivax malaria. J. Infect. Chemother. 2003, 9(3):254-256.
137. Kotwal R.S., et al. An outbreak of malaria in US Army Rangers returning from Afghanistan. JAMA 2005, 293(2):212-216.
138. Kumar S., et al. P. vivax malaria complicated by shock and ARDS. Scand. J. Infect. Dis. 2007, 39(3):255-256.
139. Kute V.B., et al. Outcome and prognostic factors of malaria-associated acute kidney injury requiring hemodialysis: a single center experience. Indian J. Nephrol. 2012, 22(1):33-38.
140. Kute V.B., et al. Plasmodium vivax malaria-associated acute kidney injury, India, 2010-2011. Emerg. Infect. Dis. 2012, 18(5):842-845.
141. Lacerda M.V., et al. Thrombocytopenia in malaria: who cares?. Mem. Inst. Oswaldo Cruz 2011, 106(Suppl. 1):52-63.
142. Lacerda M.V., et al. Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite Kill?. Clin. Infect. Dis. 2012, (p. epub ahead of print).
143. Ladeia-Andrade S., et al. Age-dependent acquisition of protective immunity to malaria in riverine populations of the Amazon Basin of Brazil. Am. J. Trop. Med. Hyg. 2009, 80(3):452-459.
144. Lampah D.A., et al. Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia. PloS Negl. Trop. Dis. 2011, 5(6):e1032.
145. Lanca E.F., et al. Risk factors and characterization of Plasmodium vivax-associated admissions to pediatric intensive care units in the Brazilian Amazon. PLoS ONE 2012, 7(4):e35406.
146. Larkin D., et al. Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition. PLoS Pathog. 2009, 5(3):e1000349.
147. Lawn S.D., et al. Case reports: pernicious complications of benign tertian malaria. Trans. R Soc. Trop. Med. Hyg. 2003, 97(5):551-553.
148. Lee J.H., et al. Retinal hemorrhage in Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 2010, 82(2):219-222.
149. Lee G., et al. Comparative effects of vivax malaria, fever and diarrhoea on child growth. Int. J. Epidemiol. 2012, 41(2):531-539.
150. Leoratti F.M., et al. Neutrophil Paralysis in Plasmodium vivax malaria. PloS Negl. Trop. Dis. 2012, 6(6):e1710.
151. Leslie T., et al. The impact of phenotypic and genotypic G6PD deficiency on risk of Plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan. PLoS Med. 2010, 7(5):e1000283.
152. Lin E., et al. Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children. PLoS ONE 2010, 5(2).
153. Littman E. Splenectomy in hereditary spherocytosis: effect on course of relapsing vivax malaria. Am. J. Med. Sci. 1974, 267(1):53-56.
154. Liu X., et al. A case of congenital Plasmodium vivax malaria from a temperate region in central China. Malar. J. 2012, 11(1):182.
155. Lomar A.V., et al. Acute respiratory distress syndrome due to vivax malaria: case report and literature review. Braz. J. Infect. Dis. 2005, 9(5):425-430.
156. Looareesuwan S., et al. Reduced erythrocyte survival following clearance of malarial parasitaemia in Thai patients. Br. J. Haematol. 1987, 67(4):473-478.
157. Lowenberg E.C., et al. Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13. Thromb. Haemost. 2010, 103(1):181-187.
158. Lubitz J. Pathology of ruptured spleen in acute vivax malaria. Blood 1949, 4:1168-1176.
159. Luxemburger C., et al. The epidemiology of malaria in a Karen population on the western border of Thailand. Trans. R Soc. Trop. Med. Hyg. 1996, 90(2):105-111.
160. Luxemburger C., et al. The epidemiology of severe malaria in an area of low transmission in Thailand. Trans. R Soc. Trop. Med. Hyg. 1997, 91(3):256-262.
161. Luxemburger C., et al. Clinical features cannot predict a diagnosis of malaria or differentiate the infecting species in children living in an area of low transmission. Trans. R Soc. Trop. Med. Hyg. 1998, 92(1):45-49.
162. Luxemburger C., et al. Effects of malaria during pregnancy on infant mortality in an area of low malaria transmission. Am. J. Epidemiol. 2001, 154(5):459-465.
163. MacPherson G.G., et al. Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am. J. Pathol. 1985, 119(3):385-401.
164. Maguire G.P., et al. Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in papua, Indonesia. J. Infect. Dis. 2005, 192(11):1966-1974.
165. Mahgoub H., et al. Severe Plasmodium vivax malaria among Sudanese children at New Halfa hospital, eastern Sudan. Parasite Vectors 2012, 5(1):154.
166. Maitland K., et al. Absence of malaria-specific mortality in children in an area of hyperendemic malaria. Trans. R Soc. Trop. Med. Hyg. 1997, 91(5):562-566.
167. Maitland K., et al. Mortality after fluid bolus in African children with severe infection. N. Engl. J. Med. 2011.
168. Manning L., et al. Features and prognosis of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed Plasmodium species in Papua New Guinean children. PLoS ONE 2011, 6(12):e29203.
169. Manning L., et al. A histopathologic study of fatal paediatric cerebral malaria caused by mixed Plasmodium falciparum/Plasmodium vivax infections. Malar. J. 2012, 11:107.
170. Manson P. Experimental Proof of the Mosquitomalaria Theory. Br. Med. J. 1900, 2(2074):949-951.
171. Marchiafava E., Bignami A. On Summer-autumnal Malaria Fevers 1894, The New Sydenham Society, London.
172. Marchiafava E., Bignami A. On Summer-Autumnal Fever 1894, New Sydenham Society, London.
173. Marsh K., et al. Indicators of life-threatening malaria in African children. N. Engl. J. Med. 1995, 332(21):1399-1404.
174. Mayxay M., et al. Mixed-species malaria infections in humans. Trends Parasitol. 2004, 20(5):233-240.
175. McGready R., et al. The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission. Am. J. Trop. Med. Hyg. 2004, 70(4):398-407.
176. McGready R., et al. Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study. Lancet Infect. Dis. 2012, 12(5):388-396.
177. McGready R., et al. Effect of early detection and treatment on malaria related maternal mortality on the north-western border of Thailand 1986-2010. PLoS ONE 2012, 7(7):e40244.
178. McQueen P.G., McKenzie F.E. Age-structured red blood cell susceptibility and the dynamics of malaria infections. Proc. Natl. Acad. Sci. U S A 2004, 101(24):9161-9166.
179. Meera S., et al. In vitro studies on peroxidative changes leading to hemolysis of erythrocytes infested with malarial parasite Plasmodium vivax. Indian J. Exp. Biol. 1999, 37(7):729-730.
180. Melo G.C., et al. Concurrent helminthic infection protects schoolchildren with Plasmodium vivax from anemia. PLoS ONE 2010, 5(6):e11206.
181. Michon P., et al. The risk of malarial infections and disease in Papua New Guinean children. Am. J. Trop. Med. Hyg. 2007, 76(6):997-1008.
182. Miller L.H., et al. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med. 1976, 295(6):302-304.
183. Miller L., et al. The pathogenic basis of malaria. Nature 2002, 415:673-679.
184. Moses W.R. Splenic rupture in therapeutic malaria. South. Med. J. 1945, 38:745.
185. Most H., Hayman J.M. Uncommon clinical manifestations of vivax malaria. J. Am. Med. Assoc. 1946, 130:480-485.
186. Munteis E., et al. Pulmonary involvement in a case of Plasmodium vivax malaria. Chest 1997, 111(3):834-835.
187. Nacher M., et al. Haematinic treatment of anaemia increases the risk of Plasmodium vivax malaria in pregnancy. Trans. R Soc. Trop. Med. Hyg. 2003, 97(3):273-276.
188. Naha K., Dasari S., Prabhu M. Spectrum of complications associated with Plasmodium vivax infection in a tertiary hospital in South-Western India. Asian Pac. J. Trop. Med. 2012, 5(1):79-82.
189. Nayak K.C., et al. Spectrum of vivax malaria in pregnancy and its outcome: a hospital-based study. J. Vector Borne Dis. 2009, 46(4):299-302.
190. Nguyen T.H., et al. Post-malaria neurological syndrome. Lancet 1996, 348(9032):917-921.
191. Nicol W. A review of seven years malaria therapy in general paresis. J. Ment. Sci. 1932, 78:843-866.
192. Nicolajev B. The duration and course of malaria infection in man. Med. Parasitol. Parasit Dis. 1939, 8:191.
193. Nosten F., et al. Effects of Plasmodium vivax malaria in pregnancy. Lancet 1999, 354(9178):546-549.
194. Nurleila S., et al. Serious and fatal illness associated with falciparum and vivax malaria among patients admitted to hospital at West Sumba in eastern Indonesia. Am. J. Trop. Med. Hyg. 2012, 87(1):41-49.
195. Nyakeriga A.M., et al. Iron deficiency and malaria among children living on the coast of Kenya. J. Infect. Dis. 2004, 190(3):439-447.
196. O'Dempsey T.J., et al. Overlap in the clinical features of pneumonia and malaria in African children. Trans. R Soc. Trop. Med. Hyg. 1993, 87(6):662-665.
197. O'Donnell A., et al. Interaction of malaria with a common form of severe thalassemia in an Asian population. Proc. Natl. Acad. Sci. U S A 2009, 106(44):18716-18721.
198. O'Leary P., Welsh A. Treatment of neurosyphilis with malaria: observations on nine hundred and eighty-four cases in the last nine years. JAMA 1933, 101:495-501.
199. Ozen M., et al. Cerebral malaria owing to Plasmodium vivax: case report. Ann. Trop. Paediatr. 2006, 26:141-144.
200. Parakh A., et al. Plasmodium vivax malaria in children: uncommon manifestations. Ann. Trop. Paediatr. 2009, 29(4):253-256.
201. Parroche P., et al. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc. Natl. Acad. Sci. U S A 2007, 104(6):1919-1924.
202. Patel M.P., et al. An unusual case of Plasmodium vivax malaria monoinfection associated with crescentic glomerulonephritis: a need for vigilance. Parasitol. Res. 2012.
203. Paulian D. Statistique surd ix ans de malaria therapie. Rev. Neurol. 1935, 63:963-965.
204. Piyaphanee W., et al. Concurrent salmonella bacteremia in P. vivax infection-a report of 2 cases at the Hospital for Tropical Diseases, Thailand. Southeast. Asian J. Trop. Med. Public Health 2007, 38(4):616-618.
205. Poespoprodjo J.R., et al. Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic. Clin. Infect. Dis. 2008, 46(9):1374-1381.
206. Poespoprodjo J.R., et al. Vivax malaria: a major cause of morbidity in early infancy. Clin. Infect. Dis. 2009, 48(12):1704-1712.
207. Poespoprodjo J.R., et al. Severe congenital malaria acquired in utero. Am. J. Trop. Med. Hyg. 2010, 82(4):563-565.
208. Poespoprodjo J.R., et al. Highly effective therapy for maternal malaria associated with a lower risk of Vertical transmission. J. Infect. Dis. 2011, 204:1613-1619.
209. Pongponratn E., et al. An ultrastructural study of the brain in fatal Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 2003, 69(4):345-359.
210. Pontororing G., et al. The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational study. BMC Infect. Dis. 2010, 10(1):362.
211. Prakash J., et al. Acute renal failure in Plasmodium vivax malaria. J. Assoc. Physicians India 2003, 51:265-267.
212. Price R.N., et al. Factors contributing to anemia after uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg. 2001, 65(5):614-622.
213. Price L., et al. Acute respiratory distress syndrome in Plasmodium vivax malaria: case report and review of the literature. Trans. R Soc. Trop. Med. Hyg. 2007, 101(7):655-659.
214. Price R.N., et al. Vivax malaria: neglected and not benign. Am. J. Trop. Med. Hyg. 2007, 77(Suppl. 6):79-87.
215. Price R.N., Douglas N.M., Anstey N.M. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr. Opin. Infect. Dis. 2009, 22:430-435.
216. Pukrittayakamee S., et al. Pulmonary oedema in vivax malaria. Trans. R Soc. Trop. Med. Hyg. 1998, 92(4):421-422.
217. Raghunandan J., et al. Peripheral gangrene in an 18-month-old boy with Plasmodium vivax malaria. Paediatr. Int. Child. Health 2012, 32(3):164-166.
218. Rajahram G.S., et al. Deaths due to Plasmodium knowlesi malaria in Sabah, Malaysia: association with reporting as Plasmodium malariae and delayed parenteral artesunate. Malar. J. 2012, 11(1):284.
219. Ratcliff A., et al. Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia. Trans. R Soc. Trop. Med. Hyg. 2007, 101(4):351-359.
220. Richard S.A., et al. Zinc and iron supplementation and malaria, diarrhea, and respiratory infections in children in the Peruvian Amazon. Am. J. Trop. Med. Hyg. 2006, 75(1):126-132.
221. Rijken M.J., et al. Malaria in pregnancy in the Asia-Pacific region. Lancet Infect. Dis. 2012, 12(1):75-88.
222. Rijken M.J., et al. Ultrasound evidence of early fetal growth restriction after maternal malaria infection. PLoS ONE 2012, 7(2):e31411.
223. Rodriguez-Morales A.J., et al. Pregnancy outcomes associated with Plasmodium vivax malaria in Northeastern Venezuela. Am. J. Trop. Med. Hyg. 2006, 74(5):755-757.
224. Rodriguez-Morales A.J., Benitez J.A., Arria M. Malaria mortality in Venezuela: focus on deaths due to Plasmodium vivax in children. J. Trop. Pediatr. 2008, 54(2):94-101.
225. Rogerson S.J., et al. Malaria in pregnancy: pathogenesis and immunity. Lancet Infect. Dis. 2007, 7(2):105-117.
226. Romanenko A.P. Two cases of comatose form of tertian malaria treated by subcutaneous injection of quinine and methylene blue. Med. Parasitol. Parasit Dis. 1936, 5:925.
227. Ross R., Thomson D. Some enumerative studies on malaria fever. Proc. R Soc. B 1911, 83:159-173.
228. Ru Y.X., et al. Invasion of erythroblasts by Plasmodium vivax: a new mechanism contributing to malarial anemia. Ultrastruct. Pathol. 2009, 33(5):236-242.
229. Rudolf G., Ramsay J. Enumeration of parasites in therapeutic malaria. J. Trop. Med. Hyg. 1927, 30:1-8.
230. Ryan J.R., et al. Evidence for transmission of Plasmodium vivax among a duffy antigen negative population in Western Kenya. Am. J. Trop. Med. Hyg. 2006, 75(4):575-581.
231. Sachdev H.P.S., Man M. Vivax cerebral malaria. J. Trop. Pediatr. 1985, 31:213-215.
232. Saharan S., et al. Thrombotic microangiopathy associated with Plasmodium vivax malaria. Pediatr. Nephrol. 2008.
233. Saleri N., et al. Acute respiratory distress syndrome in Plasmodium vivax malaria in traveler returning from Venezuela. J. Travel Med. 2006, 13(2):112-113.
234. Sarkar S., Bhattacharya P. Cerebral malaria caused by Plasmodium vivax in adult subjects. Indian J. Crit. Care Med. 2008, 12(4):204-205.
235. Sazawal S., et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 2006, 367(9505):133-143.
236. Schwarzer E., et al. Hemozoin and the human monocyte-a brief review of their interactions. Parassitologia 2008, 50(1-2):143-145.
237. Scott J.A., et al. Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study. Lancet 2011, 378(9799):1316-1323.
238. Sharma J., et al. Plasmodium vivax malaria presenting as hemolytic-uremic syndrome. Indian Pediatr. 1993, 30(3):369-371.
239. Sharma R., et al. Plasmodium vivax malaria admissions and risk of mortality in a tertiary-care children's hospital in North India. Paediatr. Int. Child. Health 2012, 32(3):152-157.
240. Shute P. Protracted incubation periods in indigenous cases of malaria in England. J. Trop. Med. 1939, 46(5):57.
241. Sim J.E., Choi Y.C., Kim W.J. Facial diplegia in Plasmodium vivax malaria. J. Clin. Neurol. 2010, 6(2):102-103.
242. Simpson J.A., et al. Red cell selectivity in malaria: a study of multiple-infected erythrocytes. Trans. R Soc. Trop. Med. Hyg. 1999, 93(2):165-168.
243. Singh N., Shukla M.M., Sharma V.P. Epidemiology of malaria in pregnancy in central India. Bull. World Health Organ 1999, 77(7):567-572.
244. Sinha A., et al. Thrombotic microangiopathy and acute kidney injury following vivax malaria. Clin. Exp. Nephrol. 2012.
245. Siqueira A.M., et al. Severe rhabdomyolysis caused by Plasmodium vivax malaria in the Brazilian Amazon. Am. J. Trop. Med. Hyg. 2010, 83(2):271-273.
246. Snounou G., White N.J. The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand. Trends Parasitol. 2004, 20(7):333-339.
247. Song H.H., et al. Clinical features of Plasmodium vivax malaria. Korean J. Intern. Med. 2003, 18(4):220-224.
248. Song J.Y., et al. Two cases of Plasmodium vivax Malaria with the clinical picture resembling toxic shock. Am. J. Trop. Med. Hyg. 2007, 77(4):609-611.
249. Spencer T.E. Haemoglobin levels in the D'Entrecasteaux Islands in relation to malaria and nutrition. Med. J. Aust. 1966, 2(23):1093-1097.
250. Stirk E. Pulmonary signs in malaria. J. R. Nav. Med. Serv. 1943, 29:272-274.
251. Stoppacher R., Adams S.P. Malaria deaths in the United States: case report and review of deaths, 1979-1998. J. Forensic Sci. 2003, 48(2):404-408.
252. Sumawinata I.W., et al. Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. Am. J. Trop. Med. Hyg. 2003, 68(4):416-420.
253. Sur D., et al. The malaria and typhoid fever burden in the slums of Kolkata, India: data from a prospective community-based study. Trans. R Soc. Trop. Med. Hyg. 2006, 100(8):725-733.
254. Suratt B.T., Parsons P.E. Mechanisms of acute lung injury/acute respiratory distress syndrome. Clin. Chest Med. 2006, 27(4):579-589. (abstract viii).
255. Suwanarusk R., et al. The deformability of red blood cells parasitized by Plasmodium falciparum and P. vivax. J. Infect. Dis. 2004, 189(2):190-194.
256. Swellengrebel N.H., de Buck A. Malaria in the Netherlands 1938, Scheltema & Holkema Ltd, Amsterdam.
257. Tan L.K., et al. Acute lung injury and other serious complications of Plasmodium vivax malaria. Lancet Infect. Dis. 2008, 8(7):449-454.
258. Tanios M.A., et al. Acute respiratory distress syndrome complicating Plasmodium vivax malaria. Crit. Care Med. 2001, 29(3):665-667.
259. Tanwar G.S., et al. Clinical profiles of 13 children with Plasmodium vivax cerebral malaria. Ann. Trop. Paediatr. 2011, 31(4):351-356.
260. Tarejev E.M., Gontayava A.A., Rotenburg S.S. Fulminating type of tertian malaria. Sov. Med. 1944, 4:12.
261. Taylor T.E., et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat. Med. 2004, 10:143-145.
262. Taylor W., et al. Respiratory manifestations of malaria. Chest 2012, 142:492-505.
263. Thapa R., et al. Childhood cerebral vivax malaria with pancytopenia. J. Pediatr. Hematol. Oncol. 2009, 31(2):116-117.
264. Thapa R., Patra V., Kundu R. Plasmodium vivax cerebral malaria. Indian Pediatr. 2007, 44:433-434.
265. Tilluckdharry C.C., et al. A case of vivax malaria presenting with pyschosis. West. Indian Med. J. 1996, 45:39-40.
266. Tjitra E., et al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 2008, 5(6):e128.
267. Torres J., et al. Acute non-cardiogenic lung injury in benign tertian malaria. Lancet 1997, 350:31-32.
268. Tran T.H., Phu N.H., Mai N.T.H., Chau T.T.H., Loc P.P., Sinh D.X., Chuong L.V., Vinh H., Waller D., Peto T.E.A., White N.J. Controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. New Engl. J. Med. 1996, 335(2):76-83.
269. Trape J.F., et al. Impact of chloroquine resistance on malaria mortality. C R Acad. Sci. 1998, 321(8):689-697.
270. Turner G.D., et al. An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am. J. Pathol. 1994, 145:1057-1069.
271. Udomsanpetch R., et al. Rosette formation by Plasmodium vivax. Trans. R Soc. Trop. Med. Hyg. 1995, 89(6):635-637.
272. Umbers A.J., Aitken E.H., Rogerson S.J. Malaria in pregnancy: small babies, big problem. Trends Parasitol. 2011, 27(4):168-175.
273. Valecha N., et al. Cerebral symptoms with P. vivax malaria. Indian Pediatr. 1992, 29:1176-1178.
274. Valecha N., et al. Congenital malaria with atypical presentation: a case report from low transmission area in India. Malar. J. 2007, 6:43.
275. Valecha N., et al. Histopathology of fatal respiratory distress caused by Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 2009, 81(5):758-762.
276. van Velthuysen M.L., Florquin S. Glomerulopathy associated with parasitic infections. Clin. Microbiol. Rev. 2000, 13(1):55-66. (table of contents).
277. Vedovato M., et al. Defective erythropoietin production in the anaemia of malaria. Nephrol. Dial. Transplant. 1999, 14(4):1043-1044.
278. Vitor-Silva S., et al. Malaria is associated with poor school performance in an endemic area of the Brazilian Amazon. Malar. J. 2009, 8:230.
279. Vottier G., et al. Congenital malaria in neonates: two case reports and review of the literature. Acta Paediatr. 2008, 97(4):505-508.
280. Wattanagoon Y., et al. Convulsions in childhood malaria. Trans. R Soc. Trop. Med. Hyg. 1994, 88(4):426-428.
281. Weber M.W., et al. Renal involvement in Gambian children with cerebral or mild malaria. Trop. Med. Int. Health 1999, 4(5):390-394.
282. Wickramasinghe S.N., Abdalla S.H. Blood and bone marrow changes in malaria. Baillieres Best Pract. Res. Clin. Haematol. 2000, 13(2):277-299.
283. Wickramasinghe S.N., et al. Dyserythropoiesis and ineffective erythropoiesis in Plasmodium vivax malaria. Br. J. Haematol. 1989, 72(1):91-99.
284. William T., et al. Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia. Emerg. Infect. Dis. 2011, 17(7):1248-1255.
285. Williams T.N., et al. High incidence of malaria in alpha-thalassaemic children. Nature 1996, 383(6600):522-525.
286. Williams T.N., et al. Plasmodium vivax: a cause of malnutrition in young children. QJM 1997, 90(12):751-757.
287. Woodruff A.W., Ansdell V.E., Pettitt L.E. Cause of anaemia in malaria. Lancet 1979, 1(8125):1055-1057.
288. World Health Organization Guidelines for the Treatment of Malaria 2010, World Health Organization.
289. Yadav D., et al. Changing profile of severe malaria in north Indian children. Indian J. Pediatr. 2012, 79(4):483-487.
290. Yeo T.W., et al. Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J. Exp. Med. 2007, 204(11):2693-2704.
291. Yeo T.W., et al. Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc. Natl. Acad. Sci. U S A 2008, 105:17097-17102.
292. Yeo T.W., et al. Relationship of cell-free hemoglobin to impaired endothelial nitric oxide bioavailability and perfusion in severe falciparum malaria. J. Infect. Dis. 2009, 200:1522-1529.
293. Yeo T.W., et al. Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia. J. Infect. Dis. 2010, 202(1):109-112.
294. Yeo T.W., et al. Increased Asymmetric Dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcome. PLoS Pathog. 2010, 6(4):e1000868.